Suckii, I agree with Bottle2. Back in the day it was all about ADAPT (and at this stage the SP still seems to be). Vax was only a big deal when the SP was well and truly under $1, and even then it was a side show.
It's not helpful to look to the vax as the main game. You should look to ADAPT and TAVR, and perhaps if AHZ is good it will get a bonus boost from a vax deal that will offset some of the huge amount of money that went into it over the years.
"Take a Closer Look", page-1226
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.86 |
Change
-0.140(1.40%) |
Mkt cap ! $209.4M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.80 | $28.00K | 2.851K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3423 | $9.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.87 | 140 | 3 |
View Market Depth
| Last trade - 12.31pm 11/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |